BioActiveAesthetics take SkinPen to IMCAS 2020
The BioAcitiveAesthetics team has recently returned from the 22nd edition of the IMCAS Annual World Congress.
Held in January 2020, the international event took place in Paris and included some world-class scientific sessions. With over 900 renowned speakers and 267 scientific sessions, this IMCAS World Congress was one of the biggest and best yet.
BioActivieAesthetics were delighted to attend the event and showcase the SkinPen to anti-ageing and skin rejuvenation experts from across the world.
Kathy Taylor-Brewin, managing director of BioActiveAesthetics – UK distributors of SkinPen – following the event said:
“We had a marvellous time at IMCAS, enjoying a busy booth in the exhibition hall. We met some of the world’s leading skin experts, some delivering great speaker sessions on the latest technologies and insights.
“The event allowed us to showcase the medical and aesthetic benefits of SkinPen – a hand-held micro needling device for use in skin rejuvenation, scar tissue remodelling, burns and collagen production.
“We were delighted with the turnout and the high level of interest into the SkinPen Precision micro needling device. It’s excellent that key industry professionals are interested in not only the device itself but how SkinPen protects against the potential of cross-contamination within micro needling treatments.
“We made some great international connections, and the feedback we had at IMCAS was very reassuring – we’re more confident than ever 2020 is going to be a big year for SkinPen.”
As well as networking sessions, guests and exhibitors were also provided with a gala dinner. Over 12,500 attendees were recorded, with over 300 exhibitors showcasing products and services.